Evidence map›Paper›PMID 22444582›Full record

ArticleJournal of the American Chemical Society2012

Proximal ligand electron donation and reactivity of the cytochrome P450 ferric-peroxo anion.

Santhosh Sivaramakrishnan, Hugues Ouellet, Hirotoshi Matsumura, Shenheng Guan, Pierre Moënne-Loccoz, Alma L Burlingame, Paul R Ortiz de Montellano

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. CYP3A Mediates an Unusual C(spAngewandte Chemie (International ed. in English) · 2024
    Article
  6. Article
  7. Article
  8. Electron Transfer Mechanism at the Interface of Multi-Heme Cytochromes and Metal Oxide.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  9. Article
  10. Article
  11. Engineering enzyme activity using an expanded amino acid alphabet.Protein engineering, design & selection : PEDS · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Spectroscopic studies of the cytochrome P450 reaction mechanisms.Biochimica et biophysica acta. Proteins and proteomics · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Santhosh SivaramakrishnanDepartment of Pharmaceutical Chemistry, University of California, 600 16th Street, San Francisco, California 94158-2517, USA.
Hugues Ouellet
Hirotoshi Matsumura
Shenheng Guan
Pierre Moënne-Loccoz
Alma L Burlingame
Paul R Ortiz de Montellano
University of California, San Francisco · USOregon Health & Science University · USWalker (United States) · US

Funding

YEAST THREONINE &SERINE KINASESP41RR001614 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2011
$24.1M
SELECTIVE DESTRUCTION OF CYTOCHROME P450 BY DRUGSR01GM025515 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2014
$5.6M
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosisR01AI074824 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 2007 to 2016
$4.3M
Nitric Oxide Reactions in MetalloenzymesR01GM074785 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MOENNE-LOCCOZ, PIERRE · 2006 to 2019
$3.8M
PURCHASE OF LTQ FT-ICR HYBRID MASS SPECTROMETER: (HEI) PROTEOMICSS10RR019934 · NCRR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BURLINGAME, ALMA L · 2004 to 2004
$1.0M
SELECTIVE DESTRUCTION OF CYTOCHROME P450 BY DRUGSR37GM025515 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1989 to 1998
–
NCRR NIH HHS P41 RR001614NCRR NIH HHS P41RR001614NCRR NIH HHS RR019934NCRR NIH HHS S10 RR019934NIAID NIH HHS AI074824NIAID NIH HHS R01 AI074824NIGMS NIH HHS GM25515NIGMS NIH HHS GM74785NIGMS NIH HHS R01 GM025515NIGMS NIH HHS R01 GM074785NIGMS NIH HHS R37 GM025515
6 · The paper itself

Abstract

CYP125 from Mycobacterium tuberculosis catalyzes sequential oxidation of the cholesterol side-chain terminal methyl group to the alcohol, aldehyde, and finally acid. Here, we demonstrate that CYP125 simultaneously catalyzes the formation of five other products, all of which result from deformylation of the sterol side chain. The aldehyde intermediate is shown to be the precursor of both the conventional acid metabolite and the five deformylation products. The acid arises by protonation of the ferric-peroxo anion species and formation of the ferryl-oxene species, also known as Compound I, followed by hydrogen abstraction and oxygen transfer. The deformylation products arise by addition of the same ferric-peroxo anion to the aldehyde intermediate to give a peroxyhemiacetal that leads to C-C bond cleavage. This bifurcation of the catalytic sequence has allowed us to examine the effect of electron donation by the proximal ligand on the properties of the ferric-peroxo anion. Replacement of the cysteine thiolate iron ligand by a selenocysteine results in UV-vis, EPR, and resonance Raman spectral changes indicative of an increased electron donation from the proximal selenolate ligand to the iron. Analysis of the product distribution in the reaction of the selenocysteine substituted enzyme reveals a gain in the formation of the acid (Compound I pathway) at the expense of deformylation products. These observations are consistent with an increase in the pK(a) of the ferric-peroxo anion, which favors its protonation and, therefore, Compound I formation.

Indexed as

BiocatalysisCytochrome P-450 Enzyme SystemElectronsLigandsMycobacterium tuberculosisCytochrome P-450 Enzyme SystemLigands

Identifiers

PMID22444582
PMCPMC3329582
OpenAlexW2023558879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.